Saruplase
Alternative Names: CG 4509; Rescupase; scu-PALatest Information Update: 24 Oct 2021
At a glance
- Originator Genentech; Grunenthal
- Class Anti-ischaemics; Plasminogen activator enzymes; Thrombolytics; Vascular disorder therapies
- Mechanism of Action Plasminogen activator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial infarction
Most Recent Events
- 26 Nov 1999 Further data from the PRIMI study have been added to the Ischaemic Heart Disease and Thrombosis therapeutic trials sections
- 08 Jun 1999 Five year data from the PRIMI study have been added to the Ischaemic Heart Disease and Thromboses therapeutic trials sections
- 19 May 1999 Discontinued-preregistration for Myocardial infarction in European Union (IV)